These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38000687)

  • 41. Latent tuberculosis infection screening in foreign-born populations: a successful mobile clinic outreach model.
    Morano JP; Zelenev A; Walton MR; Bruce RD; Altice FL
    Am J Public Health; 2014 Aug; 104(8):1508-15. PubMed ID: 24922157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of hepatitis B virus infection among pregnant women in Jos, Nigeria.
    Magaji FA; Okolo MO; Hassan Z; Shambe IH; Pam VC; Ocheke AN; Yiltok ES; Golit W; Anzaku SA; Daloek M; Ogwuche J; Imade GE; Isichie C; Mutihir JT; Oguche S; Agbaji O; Musa J; Sagay SA; Zoakah AI; Cohn SE
    Ann Afr Med; 2020; 19(3):176-181. PubMed ID: 32820729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
    Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Iglecias LM; Puga MA; Pompílio MA; Teles SA; Croda J; Lima LA; Lago BV; Martins RM; Motta-Castro AR
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1509-1515. PubMed ID: 27776593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HIV and viral hepatitis co-infection in New York City, 2000-2010: prevalence and case characteristics.
    Prussing C; Chan C; Pinchoff J; Kersanske L; Bornschlegel K; Balter S; Drobnik A; Fuld J
    Epidemiol Infect; 2015 May; 143(7):1408-16. PubMed ID: 25170631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study.
    Makuza JD; Nisingizwe MP; Rwema JOT; Dushimiyimana D; Habimana DS; Umuraza S; Serumondo J; Ngwije A; Semakula M; Gupta N; Nsanzimana S; Janjua NZ
    BMJ Open; 2020 Jul; 10(7):e036711. PubMed ID: 32660951
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.
    Shankar H; Blanas D; Bichoupan K; Ndiaye D; Carmody E; Martel-Laferriere V; Culpepper-Morgan J; Dieterich DT; Branch AD; Bekele M; Nichols K; Perumalswami PV
    Clin Infect Dis; 2016 Jun; 62 Suppl 4(Suppl 4):S289-97. PubMed ID: 27190318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Occult hepatitis B virus coinfection in HIV-positive African migrants to the UK: a point prevalence study.
    Chadwick D; Doyle T; Ellis S; Price D; Abbas I; Valappil M; Geretti AM
    HIV Med; 2014 Mar; 15(3):189-92. PubMed ID: 24118868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Universal screening for latent and active tuberculosis (TB) in asylum seeking children, Bochum and Hamburg, Germany, September 2015 to November 2016.
    Mueller-Hermelink M; Kobbe R; Methling B; Rau C; Schulze-Sturm U; Auer I; Ahrens F; Brinkmann F
    Euro Surveill; 2018 Mar; 23(12):. PubMed ID: 29589578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?
    Chiesa A; Ochola E; Oreni L; Vassalini P; Rizzardini G; Galli M
    PLoS One; 2020; 15(11):e0242278. PubMed ID: 33206693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of prevalence and risk factors associated with Hepatitis B virus infection among blood donors in Mogadishu Somalia.
    Mohamud AK; Inchon P; Suwannaporn S; Prasert K; Dirie NI
    BMC Public Health; 2024 Mar; 24(1):690. PubMed ID: 38438851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients.
    Harris AM; Millman AJ; Lora M; Osinubi A; Lom J; Miller LS
    Vaccine; 2019 Apr; 37(16):2188-2193. PubMed ID: 30902481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High prevalence of latent tuberculosis and bloodborne virus infection in a homeless population.
    Aldridge RW; Hayward AC; Hemming S; Yates SK; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    Thorax; 2018 Jun; 73(6):557-564. PubMed ID: 29378859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating hepatitis B, hepatitis C and HIV screening into tuberculosis entry screening for migrants in the Netherlands, 2013 to 2015.
    Bil JP; Schrooders PA; Prins M; Kouw PM; Klomp JH; Scholing M; Huijbregts LP; Sonder GJ; Waegemaekers TC; de Vries HJ; Meijer W; Zuure FR; Tostmann A
    Euro Surveill; 2018 Mar; 23(11):. PubMed ID: 29560855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States.
    Ferrante ND; Kallan MJ; Sukkestad S; Kodani M; Kitahata MM; Cachay ER; Bhattacharya D; Heath S; Napravnik S; Moore RD; Yendewa G; Mayer KH; Reddy KR; Hayden T; Kamili S; Martin JN; Kim HN; Lo Re V
    J Viral Hepat; 2023 Nov; 30(11):879-888. PubMed ID: 37488783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of hepatitis B and C viral co-infection and associated factors with HIV infection in children in South Kivu, Democratic Republic of the Congo.
    Miyanga SA; Shindano TA; Shindano EM; Kyambikwa CB; Kabinda JM
    BMC Infect Dis; 2023 Aug; 23(1):531. PubMed ID: 37580665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.